BIOLARGO, INC.: director Marshall Dennis E received 515,623 shares

What happened

• Marshall Dennis E, a director, received grants of derivative securities (options) covering 281,248 and 234,375 shares on Sep 30, 2026. The filing lists the exercise price as N/A and total value as N/A.

Key details

• Transaction date: Sep 30, 2026; transaction type: grant (code A).
• Securities granted: derivative securities (options) for 281,248 shares and 234,375 shares.
• Exercise price: N/A; total dollar value: N/A.
• Shares owned after the transaction: not reported in this filing.
• Footnotes in the filing:
  • F1: one option was granted to replace an option to purchase 29,605 shares that had been issued for services and expired unexercised due to a price discrepancy, pursuant to a plan adopted by the compensation committee.
  • F2: total reflects the expiration of options to purchase 29,605 shares that expired unexercised on Sep 30, 2026.
  • F3: one option was issued as payment for $18,750 in fees for board services under the issuer's 2024 Equity Incentive Plan; the number of shares in the option equals the fees due divided by the option's exercise price.
• Filing date: Oct 2, 2026. The filing does not indicate a late filing.

Why it may matter

• The filing reports grants of options (derivative securities); it does not report the sale of underlying shares or a cashless exercise.
• This filing does not show why the insider traded or why the company acted.